306 related articles for article (PubMed ID: 15652202)
1. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
[TBL] [Abstract][Full Text] [Related]
2. Gastric floating matrix tablets: design and optimization using combination of polymers.
Prajapati ST; Patel LD; Patel DM
Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
[TBL] [Abstract][Full Text] [Related]
3. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of sodium alginate as drug release modifier in matrix tablets.
Liew CV; Chan LW; Ching AL; Heng PW
Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
[TBL] [Abstract][Full Text] [Related]
5. Optimization of sustained release matrix tablet of metoprolol succinate using central composite design.
Li L; Sun H; Gao J; Jiang T; Gao Y; Zhang J
Pak J Pharm Sci; 2013 Sep; 26(5):929-37. PubMed ID: 24035948
[TBL] [Abstract][Full Text] [Related]
6. A novel system for three-pulse drug release based on "tablets in capsule" device.
Li B; Zhu J; Zheng C; Gong W
Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
[TBL] [Abstract][Full Text] [Related]
7. optimization of extended zero-order release gliclazide tablets using D-optimal mixture design.
Jin X; Zhang Y; Xiao L; Zhao Z
Yakugaku Zasshi; 2008 Oct; 128(10):1475-83. PubMed ID: 18827468
[TBL] [Abstract][Full Text] [Related]
8. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
Chatchawalsaisin J; Podczeck F; Newton JM
Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
[TBL] [Abstract][Full Text] [Related]
9. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
Shariff A; PK M; KLK P; M M
Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
[TBL] [Abstract][Full Text] [Related]
10. An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
Petrovic A; Ibric S; Trajkovic S; Popovic R; Djuric Z; Popadic D
Arch Pharm Res; 2009 Jul; 32(7):1087-96. PubMed ID: 19641891
[TBL] [Abstract][Full Text] [Related]
11. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.
Kikuchi S; Takayama K
Int J Pharm; 2010 Feb; 386(1-2):149-55. PubMed ID: 19922778
[TBL] [Abstract][Full Text] [Related]
12. Modifying matrix micro-environmental pH to achieve sustained drug release from highly laminating alginate matrices.
Ching AL; Liew CV; Chan LW; Heng PW
Eur J Pharm Sci; 2008 Apr; 33(4-5):361-70. PubMed ID: 18329253
[TBL] [Abstract][Full Text] [Related]
13. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
Mandal S; Ray R; Basu SK; Sa B
J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
Abd-Elbary A; Haider M; Sayed S
Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
[TBL] [Abstract][Full Text] [Related]
16. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system.
Patel MM; Shah TJ; Amin AF; Shah NN
Pharm Dev Technol; 2009; 14(1):62-9. PubMed ID: 18802844
[TBL] [Abstract][Full Text] [Related]
17. Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers.
Siahi-Shadbad MR; Asare-Addo K; Azizian K; Hassanzadeh D; Nokhodchi A
AAPS PharmSciTech; 2011 Dec; 12(4):1176-82. PubMed ID: 21918920
[TBL] [Abstract][Full Text] [Related]
18. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
[TBL] [Abstract][Full Text] [Related]
19. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
Tadros MI
Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
[TBL] [Abstract][Full Text] [Related]
20. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
Chakraborty S; Khandai M; Sharma A; Patra ChN; Patro VJ; Sen KK
Acta Pharm; 2009 Sep; 59(3):313-23. PubMed ID: 19819827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
